ES2187201T3 - Empleo de esteroles y de esterolesteres a nanoescala. - Google Patents

Empleo de esteroles y de esterolesteres a nanoescala.

Info

Publication number
ES2187201T3
ES2187201T3 ES99950616T ES99950616T ES2187201T3 ES 2187201 T3 ES2187201 T3 ES 2187201T3 ES 99950616 T ES99950616 T ES 99950616T ES 99950616 T ES99950616 T ES 99950616T ES 2187201 T3 ES2187201 T3 ES 2187201T3
Authority
ES
Spain
Prior art keywords
nanoescala
steroles
sterolesters
sterols
nanoscale
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99950616T
Other languages
English (en)
Inventor
Thomas Forster
Bernd Fabry
Martina Hollenbrock
Christian Kropf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Personal Care and Nutrition GmbH
Original Assignee
Cognis Deutschland GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cognis Deutschland GmbH and Co KG filed Critical Cognis Deutschland GmbH and Co KG
Application granted granted Critical
Publication of ES2187201T3 publication Critical patent/ES2187201T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/413—Nanosized, i.e. having sizes below 100 nm
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60—Particulates further characterized by their structure or composition
    • A61K2800/61—Surface treated
    • A61K2800/614—By macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/926—Topical chemical, e.g. cosmetic or sunscreen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Optics & Photonics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Empleo de esteroles y/o de esterolésteres a nanoescala con diámetros de las partículas en el intervalo desde 10 hasta 300 nm, para la fabricación de preparaciones cosméticas y/o farmacéuticas.
ES99950616T 1998-10-14 1999-10-05 Empleo de esteroles y de esterolesteres a nanoescala. Expired - Lifetime ES2187201T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10414498P 1998-10-14 1998-10-14

Publications (1)

Publication Number Publication Date
ES2187201T3 true ES2187201T3 (es) 2003-05-16

Family

ID=22298880

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99950616T Expired - Lifetime ES2187201T3 (es) 1998-10-14 1999-10-05 Empleo de esteroles y de esterolesteres a nanoescala.

Country Status (7)

Country Link
US (1) US6316030B1 (es)
EP (1) EP1121088B1 (es)
JP (1) JP2002527367A (es)
AU (1) AU6333499A (es)
DE (1) DE59903869D1 (es)
ES (1) ES2187201T3 (es)
WO (1) WO2000021490A1 (es)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19828081C2 (de) * 1998-06-24 2000-08-10 Cognis Deutschland Gmbh W/O-Emulsionsgrundlagen
US6132582A (en) 1998-09-14 2000-10-17 The Perkin-Elmer Corporation Sample handling system for a multi-channel capillary electrophoresis device
DE19911041A1 (de) * 1999-03-12 2000-09-14 Henkel Kgaa Mit Nanopartikel-Dispersionen ausgerüstete, flexible und saugfähige Träger zur Behandlung der Haut
US6515029B1 (en) 1999-04-23 2003-02-04 Kimberly-Clark Worldwide, Inc. Absorbent article having a hydrophilic lotionized bodyside liner
ATE304799T1 (de) * 1999-06-25 2005-10-15 Cognis Ip Man Gmbh Verwendung von nanoskaligen sterolen und sterolestern
DE60040850D1 (de) * 1999-07-16 2009-01-02 Calgon Corp Wasserlösliche polymerzubereitung und verfahren zu deren anwendung
DE19961278A1 (de) * 1999-12-18 2001-06-21 Cognis Deutschland Gmbh Verwendung von nanoskaligen Antischuppenwirkstoffen
DE10002643A1 (de) * 2000-01-21 2001-07-26 Cognis Deutschland Gmbh Desodorierende Zubereitungen
DE10027948A1 (de) * 2000-06-08 2001-12-20 Henkel Kgaa Verfahren zur Herstellung von Nanopartikel-Suspensionen
US6756520B1 (en) * 2000-10-20 2004-06-29 Kimberly-Clark Worldwide, Inc. Hydrophilic compositions for use on absorbent articles to enhance skin barrier
US6503526B1 (en) 2000-10-20 2003-01-07 Kimberly-Clark Worldwide, Inc. Absorbent articles enhancing skin barrier function
KR100655834B1 (ko) * 2000-11-22 2006-12-08 오츠카 세이야쿠 가부시키가이샤 Ｏ／ｗ형 유화 조성물 및 그의 조제 방법
US7771735B2 (en) 2000-12-22 2010-08-10 Kimberly-Clark Worldwide, Inc. Absorbent articles with compositions for reducing irritation response
US6749860B2 (en) 2000-12-22 2004-06-15 Kimberly-Clark Worldwide, Inc. Absorbent articles with non-aqueous compositions containing botanicals
US20020128615A1 (en) 2000-12-22 2002-09-12 Tyrrell David John Absorbent articles with non-aqueous compositions containing anionic polymers
DE10126446A1 (de) * 2001-05-31 2002-12-05 Cognis Deutschland Gmbh Haarpflegemittel mit natürlichen Ölen
EP1425355A1 (en) * 2001-07-12 2004-06-09 Eastman Kodak Company A compressed fluid formulation
DE10155200A1 (de) * 2001-11-12 2003-05-28 Skinlab Gmbh Verwendung von Cholesterin, cholesterinhaltigen Substanzen oder von den Cholesteringehalt erhöhenden Substanzen in kosmetischen und dermatologischen Zubereitungen zum Zwecke der UV-Protektion
JPWO2003047359A1 (ja) * 2001-12-07 2005-04-14 味の素株式会社 植物ステロール含有水中油型乳化物
US20030129253A1 (en) * 2002-01-03 2003-07-10 Milley Christopher J. Stable aqueous suspension
WO2003088951A1 (en) * 2002-04-15 2003-10-30 Eiffel Technologies Limited Formulation of fine particles using liquefied or dense gases
US7217432B2 (en) * 2002-04-19 2007-05-15 Cognis Corporation Vegetable substitute for lanolin
US7220432B2 (en) * 2002-04-19 2007-05-22 Cognis Corporation Vegetable substitute for lanolin
EP1511468A1 (en) * 2002-06-10 2005-03-09 Elan Pharma International Limited Nanoparticulate sterol formulations and sterol combinations
EP1374845B1 (de) * 2002-06-19 2006-08-02 Cognis IP Management GmbH Kosmetische Zubereitungen
US6998051B2 (en) * 2002-07-03 2006-02-14 Ferro Corporation Particles from supercritical fluid extraction of emulsion
BR0314443B1 (pt) * 2002-10-31 2014-12-16 Unilever Nv Composição alimentícia na forma de emulsão óleo em água contendo ésteres de esteróis de ácidos graxos vegetais e ácido fólico como estabilizante, seu preparo e uso
US7074418B2 (en) * 2002-11-18 2006-07-11 Changaris David G Conjugated fatty acid based emulsion and methods for preparing and using same
EP1795257B1 (en) 2003-07-17 2013-05-08 Unilever N.V. Method of stabilizing an edible dispersion comprising oil
CN100425525C (zh) * 2003-11-18 2008-10-15 鸿富锦精密工业（深圳）有限公司 纳米超流体
KR100603974B1 (ko) 2003-12-05 2006-07-25 김갑식 고체상 지질을 용매로 이용한 나노수준의 또는 비결정질입자의 제조 방법
EP1570833B1 (en) * 2004-03-05 2016-08-31 Kao Germany GmbH Hair treatment composition
DE102004014615A1 (de) * 2004-03-23 2005-10-13 Beiersdorf Ag Taurinhaltige Zubereitungen zur Verbesserung der Hautbarriere
US20060008498A1 (en) * 2004-07-12 2006-01-12 Chen Tzer-Fen D Nano-particle production
JP5069841B2 (ja) * 2004-12-21 2012-11-07 築野ライスファインケミカルズ株式会社 米糠から得られる植物ステロールエステルおよびトリテルペンアルコールエステルの使用方法
US8147895B2 (en) * 2005-02-17 2012-04-03 Conopco, Inc. Process for the preparation of a spreadable dispersion
AU2009328392B2 (en) 2008-12-19 2013-08-22 Upfield Europe B.V. Edible fat powders
CN102858682B (zh) 2010-03-22 2014-07-16 株式会社Bio-Synectics 纳米颗粒制备方法
US20130122179A1 (en) 2010-05-18 2013-05-16 Robert Beltman Edible fat continuous spreads
WO2011160921A1 (en) 2010-06-22 2011-12-29 Unilever Nv Edible fat powders
US8993035B2 (en) 2010-12-17 2015-03-31 Conopco, Inc. Edible water in oil emulsion
WO2012079955A1 (en) 2010-12-17 2012-06-21 Unilever Nv Process of compacting a microporous fat powder and compacted fat powder so obtained
EP2744355B1 (en) 2011-08-15 2016-09-21 Unilever N.V. Edible composition comprising sterol
JP6050822B2 (ja) * 2011-10-03 2016-12-21 モレインクス，エービー ナノ粒子、ナノ粒子の調製のための処理、および癌治療および食品関連化合物を含む医療分野における両親媒性分子または疎水性分子ための担体としてのナノ粒子の使用
CN104739662A (zh) * 2013-12-28 2015-07-01 大连美乐生物技术开发有限公司 一种多效修复防晒霜及其制备方法
AU2018255063A1 (en) 2017-04-21 2018-11-22 Bio-Synectics Inc. Method for preparing active material nanoparticles using lipid as lubricant for milling

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1165574B (de) 1960-08-08 1964-03-19 Dehydag Gmbh Verfahren zur Herstellung von als Emulgiermittel fuer Salbengrundlagen dienenden Mischestern
DE2024051C3 (de) 1970-05-16 1986-05-07 Henkel KGaA, 4000 Düsseldorf Verwendung der Veresterungsprodukte von Glycerin-Äthylenoxid-Addukten mit Fettsäuren als Rückfettungsmittel in kosmetischen Zubereitungen
LU68901A1 (es) 1973-11-30 1975-08-20
US4115313A (en) * 1974-10-08 1978-09-19 Irving Lyon Bile acid emulsions
FR2521565B1 (fr) * 1982-02-17 1985-07-05 Dior Sa Parfums Christian Melange pulverulent de constituants lipidiques et de constituants hydrophobes, procede pour le preparer, phases lamellaires lipidiques hydratees et procede de fabrication, compositions pharmaceutiques ou cosmetiques comportant des phases lamellaires lipidiques hydratees
DE3672270D1 (de) 1985-03-06 1990-08-02 Yoshikawa Oil & Fat Verfahren zur herstellung von fettsaeureestern.
FR2642305A1 (fr) * 1989-01-27 1990-08-03 Theramex Laboratoire Nouvelles compositions de dermo-cosmetologie et leur procede d'obtention
AU658608B2 (en) * 1991-03-25 1995-04-27 Astellas Pharma Europe B.V. Topical preparation containing a suspension of solid lipid particles
SE470086B (sv) * 1991-04-23 1993-11-08 Kabi Pharmacia Ab Organspecifik emulsion
SE502569C2 (sv) * 1991-05-31 1995-11-13 British Tech Group Användning av en immunologiskt inert matris av en sterol och saponiner som kan bilda sfäriska nanopartiklar med snäv storleksfördelning som läkemedelsbärare, partiklar, komposition samt kit
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
DE4426216A1 (de) 1994-07-23 1996-01-25 Merck Patent Gmbh Benzyliden-Norcampher-Derivate
DE4426215A1 (de) 1994-07-23 1996-01-25 Merck Patent Gmbh Ketotricyclo [5.2.1.0] decan-Derivate
DE4440337A1 (de) * 1994-11-11 1996-05-15 Dds Drug Delivery Services Ges Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
US5736152A (en) * 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
EP1293504A3 (de) 1996-07-08 2003-11-05 Ciba SC Holding AG Triazinderivate als UV-Filter in kosmetischen Mitteln
DE19643587A1 (de) 1996-10-22 1998-04-23 Beiersdorf Ag Antiadhäsive Sterole und Sterolderivate

Also Published As

Publication number Publication date
EP1121088B1 (de) 2002-12-18
WO2000021490A1 (de) 2000-04-20
JP2002527367A (ja) 2002-08-27
US6316030B1 (en) 2001-11-13
EP1121088A1 (de) 2001-08-08
AU6333499A (en) 2000-05-01
DE59903869D1 (de) 2003-01-30

Similar Documents

Publication Publication Date Title
CL2004000675A1 (es) Uso de una combinacion de androgeno de origen biogenico o sintetico y un estrogeno de origen biogenico o sintetico para preparar un medicamento util en el tratamiento del hipogonadismo y enfermedades hipofisis o glandula pituitaria en hombres, para e
ATE517125T1 (de) ANTIKÖRPER GEGEN ßDEATH RECEPTOR 4ß (DR4) UND DEREN VERWENDUNGEN
AU4151099A (en) Cosmetic or dermopharmaceutical composition in the form of beads and methods forpreparing same
BR9917074A (pt) Composição cosmética ou famacêutica do tipoemulsão óleo-em-água que compreende um agentebiologicamente ativo micronizado e um sistemaemulsionante apropriado e processo detratamento cosmético
DE50011218D1 (de) Verwendung von nanoskaligen sterolen und sterolestern
TR200002773T2 (tr) Alzheimer tedavisi için smilagenin ve anzurogenin-D ve bunların kullanımı.
ATE211135T1 (de) Aminocyclohexylester und ihre anwendung
HUP9601161A3 (en) Use of retinoids in cosmetic compositions or for the manufacture of pharmaceutical compositions
NZ505073A (en) Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant, useful for treating allergic, inflammatory and intestinal diseases
DK0902789T3 (da) Androstenderivater
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
IT1264530B (it) Impiego dei polisaccaridi nelle neuropatie atrofico degenerative
WO1997004788A3 (en) Use of calendula glycosides for the treatment of psoriasis
DK0869965T3 (da) Steroidnitritesterderivater anvendelige som antiinflammatoriske lægemidler
ES2231176T3 (es) Uso de beta-(1,3)-glucanos nanometricos hidrosolubles.
PT910367E (pt) Uso de acetato de vitamina e
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
ES2120667T3 (es) Sal de l-carnitina y composiciones cosmeticas y farmaceuticas que la contienen para tratamiento de dermatosis.
TR199900662T2 (xx) 1-Hidroksi-2-piridonlar�n seborik dermatit tedavisi amac�yla kullan�m�
AU2001274526A1 (en) Remedies for allergic diseases and process for producing the same
IL105947A (en) Preparation of melanin in fluorocarbons for topical use and its production
WO2001047474A3 (de) Verwendung von nanoskaligen deodorantien
AR015190A1 (es) Un polimorfo cristalino de 1,3-diciclopropilmetil-8-aminoxantina, procedimiento para su preparacion, composiciones farmaceuticas que lo contienen y su usopara la manufactura de un medicamento
DE59608611D1 (de) Topische aciclovir-zubereitung
ES2193072T3 (es) Empleo cosmetico o farmaceutico de jabones metalicos a manoescala.